Ozonated autohemotherapy: Protection of kidneys from ischemia in rats subjected to unilateral nephrectomy

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Foglieni, Chiara ^a   Fulgenzi, Alessandro ^b   Belloni, Daniela ^a   Sciorati, Clara ^a   Ferrero, Elisabetta ^a   Elena Ferrero, Maria ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NITRIC OXIDE; NITROGEN; OXYGEN; OZONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CELL METABOLISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; OZONATED AUTOHEMOTHERAPY; RAT; RENAL PROTECTION; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; UNINEPHRECTOMY; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD AUTOTRANSFUSION; DRUG EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY; METHODOLOGY; NEPHRECTOMY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD TRANSFUSION, AUTOLOGOUS; INFUSIONS, INTRA-ARTERIAL; KIDNEY; MALE; NEPHRECTOMY; OZONE; RATS; RATS, WISTAR; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 81055149769     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-61     Document Type: Article

References (28)

1. Ozone as Janus: this controversial gas can be either toxic or medically useful. Bocci V, Mediators Inflamm 2004 13 1 3 11 10.1080/0962935062000197083 15203558 (Pubitemid 38621643)
2. Ozone therapy. Di Paolo N, Bocci V, Gaggiotti E, Int J Artif Organs 2004 27 3 168 175 15112882 (Pubitemid 38594350)
3. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Giunta R, Coppola A, Luongo C, Sammartino A, Guastafierro S, Grassia A, Giunta L, Mascolo L, Tirelli A, Coppola L, Ann Hematol 2001 80 12 745 748 10.1007/s002770100377 11797116 (Pubitemid 34041432)
4. Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts. Coulson MT, Jablonski P, Howden BO, Thomson NM, Stein AN, Transplantation 2005 80 3 353 361 10.1097/01.tp.0000168214.84417.7d 16082331 (Pubitemid 41129964)
5. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM, Tilney NL, Transplantation 1993 56 3 643 650 10.1097/00007890-199309000-00028 8105570 (Pubitemid 23293031)
6. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Ajamieh HH, Berlanga J, Merino N, Sanchez GM, Carmona AM, Cepero SM, Giuliani A, Re L, Leon OS, Transpl Int 2005 18 5 604 612 10.1111/j.1432-2277.2005.00101.x 15819811 (Pubitemid 41726865)
7. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning. Pagliaro P, Chiribiri A, Mancardi D, Rastaldo R, Gattullo D, Losano G, Ital Heart J 2003 4 6 383 394 12898803 (Pubitemid 38401489)
8. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z, Arch Med Res 2008 39 2 169 178 10.1016/j.arcmed.2007.09.005 18164960 (Pubitemid 350299621)
9. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z, J Surg Res 2008 149 2 287 295 10.1016/j.jss.2007.12.756 18262565
10. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. Di Paolo N, Gaggiotti E, Galli F, Redox Rep 2005 10 3 121 130 10.1179/135100005X38888 16156950 (Pubitemid 44111141)
11. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Legrand M, Mik EG, Johannes T, Payen D, Ince C, Mol Med 2008 14 7-8 502 516 18488066
12. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, et al. J Clin Invest 2005 115 5 1232 1240 15841216 (Pubitemid 40629041)
13. Protective effect of EDTA preadministration on renal ischemia. Foglieni C, Fulgenzi A, Ticozzi P, Pellegatta F, Sciorati C, Belloni D, Ferrero E, Ferrero ME, BMC Nephrol 2006 7 5 10.1186/1471-2369-7-5 16536881 (Pubitemid 44064088)
14. Renal ischemia/reperfusion injury: functional tissue preservation by anti-activated {beta}1 integrin therapy. Molina A, Ubeda M, Escribese MM, Garcia-Bermejo L, Sancho D, Perez de Lema G, Liano F, Cabanas C, Sanchez-Madrid F, Mampaso F, J Am Soc Nephrol 2005 16 2 374 382 10.1681/ASN.2004070528 15590758 (Pubitemid 41725132)
15. Alterations in tubular epithelial cell adhesion and mechanisms of acute renal failure. Racusen LC, Lab Invest 1992 67 2 158 165 1501442
16. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR, Anal Biochem 1982 126 1 131 138 10.1016/0003-2697(82)90118-X 7181105 (Pubitemid 13203451)
17. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G, Kidney Int 1997 52 1 171 181 10.1038/ki.1997.317 9211360 (Pubitemid 27321828)
18. The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function. Ferrero E, Ferrero ME, Pardi R, Zocchi MR, FEBS Lett 1995 374 3 323 326 10.1016/0014-5793(95)01110-Z 7589563
19. CRC Handbook of Chemistry and Physics. Cleveland: Chemical Rubber Pub. Co 89 2008
20. Fluorescent dyes for cell viability: an application on prefixed conditions. Foglieni C, Meoni C, Davalli AM, Histochem Cell Biol 2001 115 3 223 229 11326750 (Pubitemid 32247199)
21. Cellfood improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced reactive oxygen species (ROS) generation. Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME, J Physiol Pharmacol 2011 62 3 287 293 21893688
22. Ischemic preconditioning prevents endothelial dysfunction, P-selectin expression, and neutrophil adhesion by preventing endothelin and O2- generation in the post-ischemic guinea-pig heart. Duda M, Czarnowska E, Kurzelewski M, Konior A, Beresewicz A, J Physiol Pharmacol 2006 57 4 553 569 17229981 (Pubitemid 46096105)
23. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Basile DP, Kidney Int 2007 72 2 151 156 10.1038/sj.ki.5002312 17495858 (Pubitemid 47067393)
24. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E, Ann Clin Lab Sci 2006 36 3 326 332 16951275 (Pubitemid 44320428)
25. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Karaman A, Turkmen E, Gursul C, Tas E, Fadillioglu E, Int J Urol 2006 13 11 1434 1441 10.1111/j.1442-2042.2006.01592.x 17083399 (Pubitemid 44657055)
26. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Addabbo F, Ratliff B, Park HC, Kuo MC, Ungvari Z, Csiszar A, Krasnikov B, Sodhi K, Zhang F, Nasjletti A, et al. Am J Pathol 2009 174 1 34 43 10.2353/ajpath.2009.080650 19095954
27. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Xu W, Koeck T, Lara AR, Neumann D, DiFilippo FP, Koo M, Janocha AJ, Masri FA, Arroliga AC, Jennings C, et al. Proc Natl Acad Sci USA 2007 104 4 1342 1347 10.1073/pnas.0605080104 17227868 (Pubitemid 46184006)
28. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Valacchi G, Bocci V, Mediators Inflamm 2000 9 6 271 276 10.1080/09629350020027573 11213910 (Pubitemid 32096980)